|
|
|
| Discovery BIO Wide Pore C5 |
| HPLC Columns and Capillaries |
| |
| Bonded Phase: |
|
Covalently-bonded pentylsilane (C5),
endcapped |
| Silica: |
|
Spherical, 3µm, 5µm and 10µm
diameters, 300Å pore diameter, |
| |
|
high purity (<10ppm metals) |
| Column IDs: |
|
0.18mm to 21.2mm |
|
| |
| Solutions for Protein and Peptide Separation Challenges |
| |
| • |
Proteomics and biotherapeutics: high
efficiency protein and hydrophobic separations |
| • |
LC/MS; no-bleed, capillary dimensions,
and pH stability |
| • |
Protein purification: Scalable from analytical
to preparative |
| • |
Enhanced lifetime and pH stability over
C4 phases |
|
|
|
|
| |
| EXCELLENT PERFORMANCE FOR LARGE MOLECULES |
| |
| Column: Discovery BIO Wide Pore C5, 15cm x
4.6mm, 5µm; Mobile Phase: (A) 0.1% (v/v) TFA in H2O:
MeCN (75:25), (B) 0.1% (v/v) TFA in H2O:
MeCN (25:75); Flow Rate: 1mL/min; Temp: 30°C; Detection:
220nm; Injection: 10µL; Sample: Protein Test Mix;
Gradient: 0-100% B in 25 min. |
| |
1. RNase (1mg/mL) (13.7kDa)
2. Cytochrome C (1mg/mL) (12.4 kDa)
3. Lysozyme (1mg/mL) (14.3 kDa)
4. Bovine Serum Albumin (2.5mg/mL) (67.0 kDa)
5. Myoglobin (1mg/mL) (18.8 kDa)
6. Ovalbumin (3.5mg/mL) (45.3 kDa) |
|
|
| |
 |
|
| INCREASED STABILITY OF DISCOVERY BIO WIDE PORE C5 OVER
CONVENTIONAL C4 |
| |
| After 25,000 column volumes (222 gradient cycles) were passed through the column, the Discovery BIO Wide Pore C5 showed very little change in efficiency. The competitive C4 column showed a significant loss of efficiency, as much as 50%. |
| |
| Column: Discovery BIO Wide Pore C5, 5cm x 4.6mm, 5µm;
Mobile Phase: (A) 0.1% TFA in H2O
: MeCN (95:5), (B) 0.1% TFA in H2O
: MeCN (25:75); Flow Rate: 2mL/min; Temp: 35°C; Detection:
220nm; Injection: 5µL; Sample: Protein/Peptide
Test Mix; Gradient: 0-20% B in 20 min |
| |
 |
|
|
| STABILITY OF DISCOVERY BIO WIDE PORE C5 AT pH 8.0 |
| |
| Retention times of the sample components remained
constant after 14,000 bed volumes were passed through the column. |
| |
| Column: Discovery BIO Wide Pore C5, 5cm x
4.6mm, 5µm; Mobile Phase: 25mM potassium phosphate, pH
8 : MeOH (95:5); Flow rate: 2mL/min; Temp: 35°C; Detection:
254nm |
 |
|
|
| UNDETECTABLE LC/MS BLEED |
| |
LC/MS Bleed Analysis on Discovery
BIO Wide Pore C5
Column: Discovery BIO Wide Pore C5, 15cm x 4.6mm, 3µm;
Mobile Phase: (A) 0.1% TFA in H2O,
(B) 0.1% TFA in MeOH; Flow Rate: 1mL/min; Temp:
30°C; Gradient: 0-100% B in 15 min, hold for 5 min, then
back to 0% B for 10 min |
| |
| No TIC baseline rise relative to blank run
(gradient run w/o column) |
|
 |
| |
| M/S Spectrum (shaded area above) |
|
 |
| |
Essentially no m/z peaks generated
from column when compared to blank run.
("X" indicates peaks also found in blank run) |
|
|
|
|
| LOT TO LOT REPRODUCIBILITY OF DISCOVERY BIO WIDE PORE
C5 |
| |
| Column: Discovery BIO Wide Pore C5, 15cm x
4.6mm, 5µm; Mobile Phase:(A) 0.1% PFPA (pentaflouropropionic
acid) in H2O : MeCN (81:19), (B) 0.1%
PFPA in H2O : MeCN (62:38); Flow Rate:
1mL/min; Temp: 30°C; Detection: 215nm; Injection:
10µL; Sample: Peptide Mix (Sigma Cat. No. P2693); Gradient:
0-100% B in 19 min. |
| |
| Peak Identity: |
Amino Acid Sequence: |
1. Arg8-vassopressin
2. Brandykinin, fragment 1-5
3. Oxytocin
4. Met-enkaphalin
5. Luteinizing Hormone Releasing Hormone
6. Leu-enkephalin
7. Brandykinin
8. Bombesin
9. Substance P |
CFQNCPRG-amide; disulfide
RPPGF
CYIQNCPLG-amide; disulfide
PEHWSYGLRPG-amide
YGGFM
YGGFL
RPPGFSPFR
PEQRLGNQWAVGHLM-amide
RPKPQQFFGLM-amide |
|
 |
|
| Ordering
Information |
| 3µm Discovery BIO Wide Pore C5 HPLC Columns |
|
|
| 5µm Discovery BIO Wide Pore C5 HPLC Columns |
|
|
| 10µm Discovery BIO Wide Pore C5 HPLC Columns |
|
|
| 2cm Supelguard Cartridges with Discovery BIO C5 Packings |
|
|
| 1cm Supelguard Cartridges with Discovery BIO C5 Packings |
| |
Description |
10mm ID |
| |
10µm Particle Size |
567286-U |
|